HEFEI HEYU PHARMATECH CO., LTD, is mainly committed to the research & development, production and sales of pharmaceutical intermediates and chemical new materials. Our advantage is that we have rich experience in the process development, pilot scale-up and industrial production of new products. At the same time, by means of share investment and contract processing, we continue to expand the product line: high-quality intermediates, novel small molecule structures, special polymer monomers and lithium battery material additives.
1.Customized R&D services include: process route screening, process development and optimization, impurity synthesis and characterization, key process parameter analysis
2. customized production services include: mg to tonnage level customized production, and production process solutions.
3.Reactions that the factory is good at: hydrogenation reduction reaction, bromination reaction, rearrangement reaction, cyclization reaction, alkylation reaction, Friedel-Crafts acylation and other conventional reactions.
4, product advantages: competitive price, excellent product quality, professional packaging and can achieve fast, safe and timely transportation.
Please find the product catalog in the attachment.
We look forward to working with you and providing you with our Quality Products, Support & Services.
Year of Establishment:
2019
Total Assets(USD):
Total Number of Staff:
Main Competitive Advantages:
Other Competitive Advantages:
Patents and Copyrights:
Business Type:
Retailer,Manufacturer
R&D capacity:
ODM
Annual Turnover(USD):
Main Sales Markets:
Western Europe,Eastern Europe,Asia
Other Competitive Advantages:
Patents and Copyrights:
Audited Supplier
Pharma Sources Insight June 2024: Globalization on the Go
![Thieno[2,3-d]pyrimidin-4(3H)-one](https://eimg.pharmasources.com/image/20240529/pvBDJ35VKuG28gvUarHQUvaIwc5NwLw38STfP87V.png!200)
![tert-Butyl 2,6-diazaspiro[3.3]heptane-2-carboxylate oxalate](https://eimg.pharmasources.com/image/20240529/sBXK22wNiDadmksH1LTTk9yHAu38os2BUXLbuKB6.png!200)
![2-Oxa-6-azaspiro[3.3]heptane oxalate](https://eimg.pharmasources.com/image/20240529/LtrnNBpi8HPMfElwXAMFL7oZJoJQUOt01PvcbXqq.png!200)
![5-Bromo-4-chloro-1H-pyrrolo[2,3-d]pyrimidine](https://eimg.pharmasources.com/image/20240529/lTbolUUcNBtURRsQ1gUSZ6DzTZmj7aFBXgKZuSf0.png!200)
![Pyrrolo[2,3-d]pyrimidin-4-ol](https://eimg.pharmasources.com/image/20240529/bUb6GmoyVt9QiJyp4YmxfivJ5vsW55A4ggKHZ0uk.png!200)
![2-Oxa-6-azaspiro[3.3]heptane](https://eimg.pharmasources.com/image/20240529/H7wDnFSqiWHHutL6BQ2ukc2TiWSpb56q7vk5buNJ.png!200)
![4-Chloro-5-iodo-7H-pyrrolo[2,3-d]pyrimidine](https://eimg.pharmasources.com/image/20240529/xwCOLz8uTp35GIhnWCRrLN7xKi3rOSGNYtW823dQ.png!200)
![4-Chloro-7H-pyrrolo[2,3-d]pyrimidine](https://eimg.pharmasources.com/image/20240529/ivV9TfiqudXQ8V6FJvEVgisLspnHAp60rmfqo8VS.png!200)
![2,6-Diazaspiro[3.3]heptane-2-carboxylic acid tert-butyl ester hemioxylate](https://eimg.pharmasources.com/image/20240529/Jkt0Ia8HoZj51GrU5clcLAHgvTZCQTEa0aOc7oRz.gif!200)
![3，5-dimethyl-Tricyclo[3.3.1.13,7]decan-1-amine](https://eimg.pharmasources.com/image/20240424/lUH93RdLyOlC1CVkl3zVn0YW9MGa4ABwRdUl79EF.gif!200)
